`U.S. Patent No. 8,754,090
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`
`COALITION FOR AFFORDABLE DRUGS IV LLC
`Petitioner
`
`
`v.
`
`
`PHARMACYCLICS, INC.
`Patent Owner
`
`__________________
`
`
`Case IPR2015-01076
`
`U.S. Patent No. 8,754,090
`TITLE: USE OF INHIBITORS OF BRUTON’S TYROSINE KINASE (BTK)
`Issue Date: June 17, 2014
`
`__________________
`
`
`MANDATORY NOTICES FOR PATENT OWNER PHARMACYCLICS,
`INC.
`
`
`Mail Stop Patent Board
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`Case IPR2015-01076
`U.S. Patent No. 8,754,090
`
`MANDATORY NOTICES FOR PATENT OWNER PHARMACYCLICS,
`INC.
`
`Patent Owner Pharmacyclics, Inc. (“Pharmacyclics” or “Patent Owner”)
`
`
`
`hereby files its mandatory notices pursuant to 37 C.F.R. § 42.8. These notices are
`
`being timely filed within 21 days of service of the Petition, which service occurred
`
`on April 20, 2015.
`
`I.
`
`
`
`REAL PARTY-IN-INTEREST (37 C.F.R. § 42.8(b)(1))
`
`The real party-in-interest for the Patent Owner is Pharmacyclics, Inc.
`
`II. RELATED MATTERS (37 C.F.R. § 42.8(b)(2))
`
`
`
`Patent Owner is currently unaware of any other proceeding that may affect,
`
`or be affected by, a decision in this proceeding.
`
`III. DESIGNATION OF LEAD AND BACK-UP COUNSEL (37 C.F.R.
`§ 42.8(b)(3))
`
`
`
`Patent Owner hereby designates the following lead counsel and back-up
`
`counsel:
`
`1. John M. Desmarais – Reg. No. 39,655 (Lead Counsel)
`
`2. Kevin K. McNish – Reg. No. 65,047 (Back-up Counsel)
`
`Address: DESMARAIS LLP
`
`
`230 Park Avenue
`
`
`New York, NY 10169
`
`
`212-351-3400 (telephone)
`
`
`212-351-3401 (facsimile)
`
`
`PharmacyclicsIPRService@desmaraisllp.com
`
`
`jdesmarais@desmaraisllp.com
`
`
`kmcnish@desmaraisllp.com
`
`
`
`
`
`
`
`
`
`
`1
`
`
`
`Case IPR2015-01076
`U.S. Patent No. 8,754,090
`
`IV. SERVICE INFORMATION (37 C.F.R. § 42.8(b)(4))
`
`
`
`Please direct all correspondence regarding this proceeding to Lead Counsel
`
`and Back-up Counsel at the address listed above. Patent Owner also consents to
`
`electronic service by email
`
`to PharmacyclicsIPRService@desmaraisllp.com,
`
`jdesmarais@desmaraisllp.com, and kmcnish@desmaraisllp.com.
`
`V.
`
`PATENT OWNER PRELIMINARY RESPONSE
`
`
`
`Patent Owner reserves the right to file a preliminary response at a later date
`
`pursuant to 37 C.F.R. § 42.107.
`
`
`
`Dated: May 11, 2015
`
`
`
`Respectfully submitted,
`
`/kkm/
`Kevin K. McNish (Reg. No. 65,047)
`kmcnish@desmaraisllp.com
`DESMARAIS LLP
`230 Park Avenue
`New York, NY 10169
`Telephone: 212-351-3400
`Facsimile: 212-351-3401
`
`Counsel for Patent Owner
`Pharmacyclics, Inc.
`
`
`
`
`
`
`
`2
`
`
`
`Case IPR2015-01076
`U.S. Patent No. 8,754,090
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned certifies that on May 11,
`
`2015, a complete copy of the foregoing was served on counsel of record for the
`Petitioner by filing this document through the Patent Review Processing System
`and by sending this document via electronic mail to the following addresses:
`
`Jeffrey S. Ward
`Registration No. 32,774
`MERCHANT & GOULD, P.C.
`10 E. Doty Street
`Suite 600
`Madison, WI 53703-3376
`Telephone: (608) 280-6751
`Facsimile: (612) 332-9081
`jward@merchantgould.com
`
`Jeffrey D. Blake, Esq.
`Registration No. 58,884
`MERCHANT & GOULD, P.C.
`191 Peachtree Street N.E.
`Suite 4300
`Atlanta, GA 30303
`Telephone: (404) 954-5040
`Facsimile: (404) 954-5099
`jblake@merchantgould.com
`
`Brent E. Routman
`(Pro Hac Vice)
`MERCHANT & GOULD, P.C.
`3200 IDS Center
`80 South 8th Street
`Minneapolis, MN 55402-2215
`Telephone: (612) 332-5300
`Facsimile: (612) 332-9081
`broutman@merchantgould.com
`
`Shane A. Brunner
`(Pro Hac Vice)
`MERCHANT & GOULD, P.C.
`10 E. Doty Street
`Suite 600
`Madison, WI 53703-3376
`Telephone: (608) 280-6753
`Facsimile: (612) 332-9081
`sbrunner@merchantgould.com
`
`Dated: May 11, 2015
`
`
`
`Respectfully submitted,
`
`/kkm/
`Kevin K. McNish (Reg. No. 65,047)
`kmcnish@desmaraisllp.com
`DESMARAIS LLP
`230 Park Avenue
`New York, NY 10169
`Telephone: 212-351-3400
`Facsimile: 212-351-3401
`
`Counsel for Patent Owner
`Pharmacyclics, Inc.
`
`
`
`3
`
`